APA (7th ed.) Citation

MC, K., GM, H., DB, R., & RH, T. (2023). The importance of patient-centred drug development for amyotrophic lateral sclerosis. Neuropathology and applied neurobiology, 49(6), e12944. https://doi.org/10.1111/nan.12944

Chicago Style (17th ed.) Citation

MC, Kiernan, Halliday GM, Rowe DB, and Tan RH. "The Importance of Patient-centred Drug Development for Amyotrophic Lateral Sclerosis." Neuropathology and Applied Neurobiology 49, no. 6 (2023): e12944. https://doi.org/10.1111/nan.12944.

MLA (9th ed.) Citation

MC, Kiernan, et al. "The Importance of Patient-centred Drug Development for Amyotrophic Lateral Sclerosis." Neuropathology and Applied Neurobiology, vol. 49, no. 6, 2023, p. e12944, https://doi.org/10.1111/nan.12944.